Actemra

Biogen, Roche, Actemra, biosimilars, FDA approval, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, tofidence

FDA Approves Biogen’s Biosimilar, Challenging Roche’s Actemra Dominance in the Market

Anika Sharma

Biogen has achieved a remarkable milestone while contemplating the future of its biosimilars division. The company proudly announced that its ...